Breast Surgeons Live
Back to Activities List
Session Title:
Best Practice Breast Care for Transgender Patients
Date & Time:
October 09, 2024, 7:00 PM–8:00 PM ET
Length:
1 Hour
CME Deadline:
October 9, 2025
Log in to access members-only content.
Target Audience:
Surgeons with a special interest in the treatment of breast disease.
Objectives:
At the end of this activity, participants will be able to define the transgender population and spectrum of gender-affirming therapies commonly used.
Description:
This webinar is designed for all clinicians involved in breast cancer prevention, screening and care. The hour will focus on considerations and recommendations for transgender patients to ensure equitable access to best-practice care.
Agenda:
Welcome and Introduction
Christa Balanoff, MD, MHPE, FACS, and Stephanie Wong, MD, MPH, FRCSC
Breast Cancer Screening for Transgender Patient: Defining the Population, Identifying High Risk Individuals & Current Screening Recommendations
Andrew Brown, DO
Breast Cancer Treatment Considerations for the Transgender Population
Elizabeth Cathcart-Rake, MD
Transgender Breast Care Programs: Removing Barriers, Necessary Components & Paths to Success
Chandler Cortina, MD, MS, FSSO, FACS
Q&A
Faculty:
Moderator—Christa Balanoff, MD, MHPE, FACS
University of Kansas Breast Surgery Center
Kansas City, KS
Moderator—Stephanie Wong, MD, MPH, FRCSC
McGill Medical School
Montreal, QC
Canada
Canada
Andrew Brown, DO
University of Kansas Medical Center
Overland Park, KS
Elizabeth Cathcart-Rake, MD
Mayo Clinic
Rochester, MN
Chandler Cortina, MD, MS, FSSO, FACS
Medical College of Wisconsin
Milwaukee, WI
References:
- Brown et al. ACR Appropriateness Criteria® Transgender Breast Cancer Screening. Available at https://www.acr.org/Clinical-Resources/ACR-Appropriateness-Criteria.
- Breast Cancer Screening for Transgender People. Available at https://www.komen.org/breast-cancer/screening/when-to-screen/transgender-people/.
- Cathcart-Rake, E.J., et al., Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals. Maturitas, 2024. 181: p. 107913.
- Chowdhury, A., et al., Review of Breast Imaging in Transgender and Gender-Diverse Patients: Gender-Affirming Care, Histopathologic Findings, Breast Cancer Risk, and Screening Recommendations. J Breast Imaging, 2024. 6(3): p. 238-245.
- Istl, A.C., et al., Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients. Ann Surg Oncol, 2024.
- Ramsey, I., et al., Culturally safe, appropriate, and high-quality breast cancer screening for transgender people: A scoping review. Int J Transgend Health, 2023. 24(2): p. 174-194.
Disclosures:
Use the link below to view disclosure information for all individuals and groups involved in the planning, implementation, and evaluation of this educational activity.
View Disclosure Information (pdf)
View Disclosure Information (pdf)
